LivaNova PLC (LIVN) — Fair Value Analysis
Base-case fair value (P50): $89.92 · Current price: $78.50 · Verdict: Fairly Valued
The Verdict on LIVN
LIVANOVA PLC (LIVN) appears undervalued based on our latest Monte Carlo simulations. The analysis indicates a median fair value (P50) of $89.92, presenting a substantial +14.5% upside from the current market price of $78.50. This quantitative assessment suggests the market may not fully reflect LIVN's intrinsic value, offering a potential opportunity for investors. LIVN's strong quality tier further supports this conviction, signaling robust underlying operational and financial health.
Our simulations account for a wide range of future scenarios, underpinning the undervalued verdict. The discrepancy between the current trading price of $78.50 and the calculated fair value of $89.92 highlights the potential for price appreciation as the market converges with fundamental drivers. This robust methodology helps filter out short-term noise, focusing on the long-term value proposition of LIVN.
How LIVN stacks up against peers
LIVN's strong quality tier indicates solid operational and financial health when compared to its broader sector. This favorable positioning contributes significantly to the Monte Carlo simulation's $89.92 fair value, which stands markedly above the current market price of $78.50. The company's resilience and fundamental strength are key factors driving the positive fair value assessment.
While specific sector comparisons are dynamic, LIVN's strong standing suggests it possesses attributes that underpin its long-term potential. This financial and operational health, reflected in our modeling, is a primary driver behind the projected +14.5% upside. The market's current valuation at $78.50 does not fully price in this inherent strength, pointing to a potential disconnect.
What this means for investors
For investors considering LIVN, the Monte Carlo analysis clearly points to an undervalued equity. The projected +14.5% potential, derived from the difference between the current $78.50 and the median fair value of $89.92, provides a data-driven basis for evaluating an entry point. This significant gap, combined with LIVN's strong quality tier, paints a compelling picture.
FairCurve's in-depth simulations suggest a favorable risk/reward profile for LIVN. To explore the full probability distribution, including detailed bear and bull case scenarios, and track LIVN's fair value as new fundamentals are released, sign up for a FairCurve account.
Frequently Asked Questions
Is LIVN overvalued or undervalued right now?
Based on our Monte Carlo simulations, LIVN is currently undervalued. Our median fair value (P50) for LIVN is $89.92, which is above its current price of $78.50.
What is the bear case and bull case for LIVN?
The full Monte Carlo distribution, including detailed bear (P10) and bull (P90) targets and the probability of achieving upside, is available when you sign up for a free FairCurve account.
How does FairCurve calculate LIVN's fair value?
FairCurve calculates LIVN's fair value using advanced Monte Carlo simulations. This involves running thousands of forward scenarios to determine a robust median fair value and a comprehensive probability distribution.
How can I track LIVN's fair value as it changes?
You can add LIVN to your free FairCurve watchlist to receive daily fair-value updates. FairCurve will also instantly re-evaluate LIVN's fair value when new earnings or significant fundamental data are released.